Upgrades:
Amgen (NASDAQ:AMGN) was upgraded by research analysts at Raymond James from a “market perform” rating to an “outperform” rating in a research report issued on Monday, Briefing.com reports. The brokerage presently has a $255.00 price objective on the medical research company’s stock. Raymond James’ price target indicates a potential upside of 12.26% from the company’s previous close.
AMGN has been the subject of several other reports. SunTrust
Banks upped their target price on Amgen from $254.00 to $268.00 and gave the
company a “buy” rating in a report on Thursday, July 30th. Jefferies Financial
Group upped their target price on Amgen from $285.00 to $300.00 and gave the
company a “buy” rating in a report on Wednesday, July 29th. Oppenheimer reduced
their target price on Amgen from $280.00 to $275.00 and set an “outperform”
rating for the company in a report on Thursday. Cantor Fitzgerald upped their
target price on Amgen from $263.00 to $279.00 and gave the company an
“overweight” rating in a report on Wednesday, July 29th. Finally, JPMorgan
Chase & Co. reaffirmed a “hold” rating on shares of Amgen in a report on
Tuesday, September 22nd. Three investment analysts have rated the stock with a
sell rating, twelve have given a hold rating and sixteen have issued a buy
rating to the company’s stock. The company currently has a consensus rating of
“Hold” and an average price target of $254.88. Read
more …
Atlantic Securities assumed coverage on shares of Apple (NASDAQ:AAPL) in a report issued on Monday, The Fly reports. The firm set an “overweight” rating on the iPhone maker’s stock.
Other research analysts also recently issued research
reports about the company. Jefferies Financial Group raised their target price
on Apple from $135.00 to $140.00 and gave the stock a “buy” rating in a
research note on Wednesday, October 14th. ValuEngine downgraded Apple from a
“buy” rating to a “hold” rating in a research note on Thursday, October 1st.
Wolfe Research began coverage on Apple in a report on Friday, July 24th. They
issued an “underperform” rating and a $78.75 price target on the stock. BNP
Paribas raised Apple from an “underperform” rating to an “outperform” rating
and raised their price target for the company from $77.00 to $140.00 in a
report on Friday, September 25th. Finally, Macquarie reaffirmed a “hold” rating
and issued a $66.60 price target on shares of Apple in a report on Tuesday,
September 8th. Three investment analysts have rated the stock with a sell
rating, seventeen have issued a hold rating, twenty-eight have issued a buy
rating and one has issued a strong buy rating to the company. Apple currently
has an average rating of “Buy” and an average target price of $108.73. Read
more …
Archer-Daniels-Midland (NYSE:ADM) was upgraded by investment analysts at Monness Crespi & Hardt from a “neutral” rating to a “buy” rating in a research note issued on Monday, Anlyst Ratings reports. The firm presently has a $60.00 price objective on the stock. Monness Crespi & Hardt’s target price points to a potential upside of 15.67% from the company’s previous close.
A number of other equities analysts also recently commented
on the company. Stephens assumed coverage on Archer-Daniels-Midland in a report
on Thursday, July 9th. They set a “buy” rating and a $52.00 target price for
the company. Seaport Global Securities initiated coverage on shares of
Archer-Daniels-Midland in a research report on Tuesday, July 28th. They issued
a “buy” rating and a $51.00 target price for the company. JPMorgan Chase &
Co. raised shares of Archer-Daniels-Midland from a “neutral” rating to an
“overweight” rating and set a $60.00 target price on the stock in a research
note on Monday, October 19th. Stifel Nicolaus decreased their price target on
shares of Archer-Daniels-Midland from $48.00 to $47.00 and set a “buy” rating
for the company in a research note on Tuesday, June 30th. Finally, Morgan
Stanley lifted their price objective on Archer-Daniels-Midland from $40.00 to
$45.00 and gave the company an “equal weight” rating in a research report on
Monday, August 10th. Two equities research analysts have rated the stock with a
sell rating, two have assigned a hold rating and seven have assigned a buy
rating to the company’s stock. Archer-Daniels-Midland has a consensus rating of
“Hold” and a consensus price target of $48.40. Read
more …
American Express (NYSE:AXP) was upgraded by research analysts at DZ Bank from a “hold” rating to a “buy” rating in a report issued on Tuesday, Briefing.com reports. The firm currently has a $118.00 price target on the payment services company’s stock. DZ Bank’s price target would suggest a potential upside of 21.80% from the company’s current price.
A number of other analysts have also weighed in on the
stock. Oppenheimer reiterated a “buy” rating on shares of American Express in a
research note on Sunday. Morgan Stanley increased their price objective on
shares of American Express from $114.00 to $115.00 and gave the stock an
“overweight” rating in a research note on Monday, October 5th. Bank of America
lowered shares of American Express from a “neutral” rating to an “underperform”
rating and cut their price objective for the stock from $106.00 to $95.00 in a
research note on Wednesday, September 23rd. Compass Point increased their price
objective on shares of American Express from $78.00 to $85.00 and gave the
stock a “neutral” rating in a research note on Thursday, July 2nd. Finally,
Wolfe Research initiated coverage on shares of American Express in a research
report on Friday, July 31st. They set an “outperform” rating on the stock. Six
equities research analysts have rated the stock with a sell rating, twelve have
given a hold rating and nine have issued a buy rating to the company’s stock.
The company currently has a consensus rating of “Hold” and a consensus price
target of $105.04. Read
more …